The science behind non-psychotropic phytocannabinoids such as cannabidiol (CBD) is growing rapidly – a new and exciting field of research with promising findings in a wide variety of health areas including central nervous system (CNS) diseases, pain disorders, cancer and more. This is creating a myriad of opportunities to expand treatment strategies and support global patient health through the development of bespoke CBD-based drug products.